MX2023001536A - Nuevo compuesto de cicloalquenona o sal del mismo. - Google Patents

Nuevo compuesto de cicloalquenona o sal del mismo.

Info

Publication number
MX2023001536A
MX2023001536A MX2023001536A MX2023001536A MX2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A MX 2023001536 A MX2023001536 A MX 2023001536A
Authority
MX
Mexico
Prior art keywords
salt
compound
active ingredient
therapeutic agent
novel
Prior art date
Application number
MX2023001536A
Other languages
English (en)
Spanish (es)
Inventor
Takahisa Noma
Kazuhiko Shigeno
Atsushi Hakozaki
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MX2023001536A publication Critical patent/MX2023001536A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
MX2023001536A 2020-08-07 2021-08-06 Nuevo compuesto de cicloalquenona o sal del mismo. MX2023001536A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020135328 2020-08-07
PCT/JP2021/029246 WO2022030606A1 (ja) 2020-08-07 2021-08-06 新規なシクロアルケノン化合物又はその塩

Publications (1)

Publication Number Publication Date
MX2023001536A true MX2023001536A (es) 2023-03-08

Family

ID=80118163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023001536A MX2023001536A (es) 2020-08-07 2021-08-06 Nuevo compuesto de cicloalquenona o sal del mismo.

Country Status (11)

Country Link
US (1) US20230295068A1 (https=)
EP (1) EP4194435A4 (https=)
JP (1) JP7109705B2 (https=)
KR (1) KR20230043923A (https=)
CN (1) CN116096361B (https=)
AU (1) AU2021321705B2 (https=)
BR (1) BR112023001832A2 (https=)
CA (1) CA3188292A1 (https=)
MX (1) MX2023001536A (https=)
TW (1) TWI829001B (https=)
WO (1) WO2022030606A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4477642A4 (en) * 2022-02-09 2026-02-25 Taiho Pharmaceutical Co Ltd CRYSTALLINE FORM OF CYCLOHEXENONE COMPOUND

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228893B1 (en) * 1997-08-13 2001-05-08 Meiji Milk Products Co., Ltd. Cyclohexenone long-chain alcohol and medicament containing same
JP3836684B2 (ja) 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
WO2009111576A2 (en) 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
CA2883879A1 (en) 2012-09-07 2014-03-13 Edison Pharmaceuticals, Inc. Quinone derivatives for use in the modulation of redox status of individuals
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
ES2849425T3 (es) 2016-01-22 2021-08-18 Taiho Pharmaceutical Co Ltd Método de fabricación de alcohol de cadena larga de ciclohexenona de alta pureza
TWI831738B (zh) * 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物

Also Published As

Publication number Publication date
CA3188292A1 (en) 2022-02-10
TW202216650A (zh) 2022-05-01
US20230295068A1 (en) 2023-09-21
JP7109705B2 (ja) 2022-07-29
TWI829001B (zh) 2024-01-11
BR112023001832A2 (pt) 2023-02-23
WO2022030606A1 (ja) 2022-02-10
KR20230043923A (ko) 2023-03-31
JPWO2022030606A1 (https=) 2022-02-10
CN116096361A (zh) 2023-05-09
EP4194435A1 (en) 2023-06-14
AU2021321705B2 (en) 2024-02-29
AU2021321705A1 (en) 2023-03-09
EP4194435A4 (en) 2024-09-25
CN116096361B (zh) 2025-10-10

Similar Documents

Publication Publication Date Title
CO2022008344A2 (es) Derivados de pirazolilo útiles como agentes anticancerígenos
BR112023020442A2 (pt) Inibidor da protease 1 específica de ubiquitina (usp1)
CL2020003011A1 (es) Compuesto de benzimidazol o sal del mismo, agente insecticida y acaricida para la agricultura y horticultura que contiene dicho compuesto, y método para usar el mismo
PY2146661A (es) Compuestos para el tratamiento de enfermedades y trastornos asociados a braf
DOP2024000039A (es) Derivados de quinolina como inhibidores de la integrina alfa4beta7
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
MX2023006504A (es) Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo.
PE20220954A1 (es) Compuesto de 2,6-dioxo-3,6-dihidropirimidina, bactericida agricola y horticola, nematicida y agente antifungico medico y veterinario
DOP2012000128A (es) Inhibidores de n1-pirazoloespirocetona acetil-coa carboxilasa
MX2018008671A (es) Composicion para incrementar la expresion de pgc-1alfa.
MX2024006251A (es) Compuesto quimerico para la degradacion dirigida de la proteina del receptor de androgenos, metodo de preparacion y uso medico del mismo.
ES3060711T3 (en) 3-hydroxy-5-pregnane-20-one derivative and use thereof
MX2024002696A (es) Derivados del acido 2-amino-5,5-dimetilhexanoico como moduladores de sortilina para su uso en el tratamiento de enfermedades del sistema nervioso central.
AR056369A1 (es) Compuestos derivados de quinazolina y composicion farmaceutica
MX2022003830A (es) Compuesto de n-(1h-imidazol-2-il)benzamida y composicion farmaceutica que comprende el mismo como ingrediente activo.
JOP20250057A1 (ar) مركبات لعلاج السرطان
CO2022008616A2 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma
ZA202403327B (en) Halogenated phenylarsine oxide compound and application thereof
MX2023001536A (es) Nuevo compuesto de cicloalquenona o sal del mismo.
MX2023011297A (es) Antagonista del dominio de alfa/beta hidrolasa 6 (abhd6).
AR109012A1 (es) Sistema de administración transdérmica que contiene galantamina o sales de esta
MX2021011007A (es) Farmaco y método para tratar o prevenir las complicaciones de la diabetes mediante el uso del mismo farmaco.
BR112021019779A2 (pt) Novo composto e composição para prevenção ou tratamento de doenças respiratórias compreendendo os mesmos como ingrediente ativo
ZA202400679B (en) Dimethyl-substituted thiazololactam compound and use thereof
AR060494A1 (es) Compuestos antibacterianos